Site Editor

William J. Gradishar, MD, FACP, FASCO

Advertisement

Advertisement

News

SABCS 2024: Risk-Reducing Surgery in BRCA Carriers With Early-Onset Breast Cancer?

News

SABCS 2024: Margetuximab vs Trastuzumab Combinations in Early HER2-Positive Breast Cancer

Medical Literature

Novel Treatment Combinations With Imlunestrant for Advanced Breast Cancer

News

SABCS 2024: Correlation of Biomarkers With Outcomes in Early Triple-Negative Breast Cancer

News

Multilevel Chronic Stress and the Tumor Immune Environment: Is There a Connection?

News

Could Manuka Honey Be Beneficial in Treating Estrogen-Positive Breast Cancer?

Medical Literature

Cognitive Difficulties and Return to Work 2 Years After Breast Cancer Diagnosis

Komal Jhaveri, MD, FACP, on Advanced Breast Cancer: Adding a PI3K Inhibitor to the Treatment Mix

Cynthia X. Ma, MD, PhD, on Copanlisib, Fulvestrant, and Abemaciclib for HER2-Positive Breast Cancer: New on the Scene

View More

Advertisement

JNCCN Spotlights

(UPDATE) Fam-Trastuzumab Deruxtecan-nxki

(UPDATE) Talazoparib in Breast Cancer

(UPDATE) Neratinib in Breast Cancer

Fulvestrant

Talazoparib (Breast Cancer)

(UPDATE) Pertuzumab in Breast Cancer

(UPDATE) Ribociclib in Breast Cancer

Fam-trastuzumab Deruxtecan-nxki

View More

More

News

ASTRO 2024: Noninferiority Trial of Hypofractionated Radiation Schedules After Mastectomy

ESMO 2024: Chemotherapy-Free Immunotherapy for Immunogenic Triple-Negative Breast Cancer

Novel CKD4/6 Inhibitor Under Study in Advanced Breast Cancer

Pregnancy-Related Factors May Influence Breast Cancer Risk, Study Finds

ESMO 2024: Supplementary Biomarker Analyses of DAISY Trial of T-DXd in Metastatic Breast Cancer

Could Manuka Honey Be Beneficial in Treating Estrogen-Positive Breast Cancer?

SABCS 2024: Risk-Reducing Surgery in BRCA Carriers With Early-Onset Breast Cancer?

ESMO 2024: DESTINY-Breast12 Supports T-DXd in Patients With HER2-Positive Breast Cancer and Brain Metastases

View More

Advertisement

Published

Medical Literature

Predicting Breast Cancer–Related Lymphedema Among Women of Different Races

Connection Between Obesity and Breast Cancer Prognosis: More Data Emerge

Heart of the Matter: Cardiac Rehabilitation After Chemotherapy for Early-Stage Breast Cancer

After Mastectomy: Comparing Conventional and Hypofractionation Proton Radiotherapy

View More

Ongoing

CE Activities

Keeping the Outcome in Mind: Applying Best Practices for Managing HR+/HER2- EBC at High Risk of Recurrence

Breast Cancer Prevention, Screening, Diagnosis, and Treatment

The Role of Lifestyle and the Environment in Breast Cancer Risk

Recorded Presentations from the NCCN 2023 Breast Cancer Congress With Updates From The 2022 San Antonio Breast Cancer Symposium

View More

Available

Clinical Trials

Older Breast Cancer Patients: Risk for Cognitive Decline

Tomosynthesis Mammographic Imaging Screening Trial (TMIST) EA1151

A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)

A Randomized Phase II Window-of-opportunity Trial of Ruxolitinib in Patients with High Risk and Premalignant Breast Conditions

View More

Resources

For Your Patients

After Breast Cancer Diagnosis (ABCD)

Breast Cancer Research Foundation

Breastcancer.org

Facing Our Risk of Cancer Empowered

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2024 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.